Abstract
Diffuse alveolar hemorrhage (DAH) is a severe complication that can arise from various conditions, including COVID-19. This case report describes a 37-year-old Caucasian male with mild asthma and obesity who developed diffuse alveolar hemorrhage (DAH) following a COVID-19 infection. Despite initial treatment, his respiratory status deteriorated, leading to intubation and venovenous extracorporeal membrane oxygenation (VV ECMO). Multiple complications followed, culminating in multi-organ failure and his death. This case highlights the complexity of managing DAH in severe COVID-19 and underscores the importance of early recognition and a multidisciplinary approach. Additionally, a literature review compares similar cases to analyze outcomes and management strategies.